Rajiv Sarman Shukla
Chief Executive Officer chez CARMELL CORPORATION
Fortune : 6 M $ au 31/03/2024
Profil
Rajiv Sarman Shukla was the founder of Constellation Alpha Capital Corp.
(founded in 2015) where he held the title of Chairman & Chief Executive Officer.
He is currently the Chairman & Chief Executive Officer at Carmell Corp., Director at InflammX Therapeutics, Inc., and Director at Humacyte, Inc. Mr. Shukla's former positions include Chief Executive Officer at Reliance Naval & Engineering Ltd., Chairman & Chief Executive Officer at Venturcap Financial Group LLC, and various director roles at companies such as Alpha Healthcare Acquisition Corp., OcuNexus Therapeutics, Inc., Malladi Drugs & Pharmaceuticals Ltd., Avantor Performance Materials India Ltd., Arch Pharmalabs Ltd., Unimark Remedies Ltd., Avendus Capital Pvt Ltd., Bharat Biotech International Ltd., I-VEN Medi-care India Pvt Ltd., Swiss Bio Pharma Pvt Ltd., Morgan Stanley Investment Management Pvt Ltd., and ICICI Venture Funds Management Co. Ltd.
Mr. Shukla's education includes a graduate degree from Harvard University, an undergraduate degree from Indian Institute of Technology Madras, and an undergraduate degree from Banaras Hindu University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HUMACYTE, INC.
1,55% | 15/06/2023 | 1 814 789 ( 1,55% ) | 6 M $ | 31/03/2024 |
| 01/12/2023 | 34 179 ( 0,15% ) | 87 498 $ | 31/03/2024 |
Postes actifs de Rajiv Sarman Shukla
| Sociétés | Poste | Début |
|---|---|---|
| HUMACYTE, INC. | Director/Board Member | 26/08/2021 |
| CARMELL CORPORATION | Chief Executive Officer | 31/08/2023 |
InflammX Therapeutics, Inc.
 InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | Director/Board Member | 01/08/2019 |
Anciens postes connus de Rajiv Sarman Shukla
| Sociétés | Poste | Fin |
|---|---|---|
Constellation Alpha Capital Corp.
 Constellation Alpha Capital Corp. Financial ConglomeratesFinance Constellation Alpha Capital Corp. is a blank check company, which engages in the in a share exchange, share reconstruction, amalgamation, acquisition, and business combination with businesses or entities. The company was founded by Rajiv Sarman Shukla on July 31, 2015 and is headquartered in West Palm Beach, FL. | Chief Executive Officer | 01/08/2019 |
| Venturcap Financial Group LLC | Chief Executive Officer | 01/01/2019 |
| RELE NAVAPAR | Chief Executive Officer | 01/05/2015 |
| PFIZER, INC. | Director/Board Member | 01/01/2006 |
I-VEN Medi-care India Pvt Ltd.
 I-VEN Medi-care India Pvt Ltd. MiscellaneousMiscellaneous I-VEN Medicare India Pvt Ltd. provides investment services in the healthcare sectors. It invests in hospitals and research institutes. The company is headquartered in Bangalore, India. | Corporate Officer/Principal | - |
Formation de Rajiv Sarman Shukla
| Harvard University | Graduate Degree |
| Indian Institute of Technology Madras | Undergraduate Degree |
| Banaras Hindu University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| RELE NAVAPAR | Producer Manufacturing |
| HUMACYTE, INC. | Health Technology |
| Entreprise privées | 17 |
|---|---|
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Health Technology |
Morgan Stanley Investment Management Pvt Ltd.
 Morgan Stanley Investment Management Pvt Ltd. Investment Banks/BrokersFinance Morgan Stanley Investment Management Pvt Ltd. (India) (MSIM), founded in 1993, is an asset management subsidiary of Morgan Stanley (NYSE: MS). The firm specializes in managing assets for a range of institutional clients, including endowments, foundations, pension funds, corporations, governments, and high-net worth individuals. The Mumbai office focuses on managing portfolios of Indian securities. MSIM has offices in New York, Philadelphia, Houston, Chicago, London, Tokyo, Amsterdam and Singapore. | Finance |
ICICI Venture Funds Management Co. Ltd.
 ICICI Venture Funds Management Co. Ltd. Investment ManagersFinance ICICI Venture Funds Management Co. Ltd (ICICI) is a Private Equity firm, a subsidiary of ICICI Bank Ltd. founded in 1988. The firm is headquartered in India. | Finance |
Malladi Drugs & Pharmaceuticals Ltd.
 Malladi Drugs & Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Malladi Drugs & Pharmaceuticals Ltd. manufactures active pharmaceutical ingredients. It manufactures Ephedrine and Pseudo-Ephedrine. The firm's products include active pharmaceutical ingredients, intermediates and speciality products,and chiral building blocks and speciality chemicals. Its services include contract manufacturing, custom synthesis and contract research. The company was founded by M. L. N. Satry in 1980 and is headquartered in Chennai, India. | Health Technology |
Avantor Performance Materials India Ltd.
 Avantor Performance Materials India Ltd. Pharmaceuticals: MajorHealth Technology Avantor Performance Materials India Ltd. manufactures and distributes pharmaceutical products. Its products include acids, amino acids, aqueous solutions, biological regents and denaturants. The company was founded by John Townsend Baker in 1904 and is headquartered in Gurgaon, India. | Health Technology |
Arch Pharmalabs Ltd.
 Arch Pharmalabs Ltd. Pharmaceuticals: MajorHealth Technology Arch Pharmalabs Ltd. manufactures and sells pharmaceutical products. Its therapeutic segments include side chains of Semi-Synthetic Isoxazole Penicillins under Antibiotics, Lipid Lowering Agents, Oncology, Anti-Platelet Agents, Anti-Asthmatic, Anti-Retroviral, Decongestant, Anti-Herpes, Anti-Malarial, NSAIDs and Anti-Anginal segments. The company was founded in 1975 and is headquartered in Mumbai, India. | Health Technology |
Unimark Remedies Ltd.
 Unimark Remedies Ltd. Pharmaceuticals: MajorHealth Technology Unimark Remedies Ltd. develops and markets active generic medicines. It specializes in pharmaceutical products for respiratory, cardiovascular, anti-infectives, and central nervous system. The company was founded in 1982 and is headquartered in Mumbai, India. | Health Technology |
Avendus Capital Pvt Ltd.
 Avendus Capital Pvt Ltd. Investment Banks/BrokersFinance Avendus Capital Pvt Ltd. provides financial services. The firm offers financial advisory, mergers and acquisitions, private equity syndication, equity capital markets, structured finance, financial sponsors group, wealth management, alternative asset management, and institutional equities. The company was founded by Ranu Vohra, Gaurav Deepak and Kaushal Aggarwal and is headquartered in Mumbai, India. | Finance |
Bharat Biotech International Ltd.
 Bharat Biotech International Ltd. BiotechnologyHealth Technology Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India.. | Health Technology |
I-VEN Medi-care India Pvt Ltd.
I-VEN Medi-care India Pvt Ltd. MiscellaneousMiscellaneous I-VEN Medicare India Pvt Ltd. provides investment services in the healthcare sectors. It invests in hospitals and research institutes. The company is headquartered in Bangalore, India. | Miscellaneous |
| Swiss Bio Pharma Pvt Ltd. | |
Constellation Alpha Capital Corp.
Constellation Alpha Capital Corp. Financial ConglomeratesFinance Constellation Alpha Capital Corp. is a blank check company, which engages in the in a share exchange, share reconstruction, amalgamation, acquisition, and business combination with businesses or entities. The company was founded by Rajiv Sarman Shukla on July 31, 2015 and is headquartered in West Palm Beach, FL. | Finance |
| Venturcap Financial Group LLC | |
Alpha Healthcare Acquisition Corp.
 Alpha Healthcare Acquisition Corp. Financial ConglomeratesFinance Alpha Healthcare Acquisition Corp. operates as a blank check company, which is formed in order to effect a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination with one or more businesses or entities. The company was founded on July 1, 2020 and is headquartered in New York, NY. | Finance |
InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | Commercial Services |
Alpha Healthcare Acquisition Corp. III
 Alpha Healthcare Acquisition Corp. III Financial ConglomeratesFinance Alpha Healthcare Acquisition Corp. III is a blank check company, which engages in the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 21, 2021 and is headquartered in New York, NY. | Finance |
| Carmell Therapeutics Corp. |
